Immune recognition of cancer

Our research ambition is to dissect how the human immune system can recognize cancer cells, and how such recognition can be strengthened for therapeutic purposes. To achieve this goal we employ a technology-driven approach, in which novel assay systems are designed that can be used to determine how tumor-specific immune responses develop and are regulated. This technological toolbox is then exploited to reveal the mode of action of clinically used immunotherapies and to design more specific and more effective immune interventions.


This site uses cookies

This website uses cookies to ensure you get the best experience on our website.